vaccine adjuvant comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2025-12-06. Where a claim depends on a specific study, the study is described rather than over-claimed.
Reverse-phase high-performance liquid chromatography is the standard technique for assessing purity and concentration, because the peptide's hydrophobicity allows clean separation from related impurities. Mass spectrometry confirms molecular identity and detects sequence errors or truncations. Amino acid analysis and peptide mapping supply additional structural confirmation when required. Chromatographic purity values reported on certificates of analysis describe the proportion of the main peak and do not by themselves establish biological activity.
Like most short peptides, thymosin alpha-1 is susceptible to hydrolysis under strongly acidic or basic conditions and to oxidation when exposed to air over long periods. The acetylated amino terminus blocks one common degradation route, which contributes to the molecule's relative robustness in solution. Lyophilized material generally retains potency for extended periods when kept cold and dry. Once reconstituted, aqueous solutions are less stable and are typically used within a defined window rather than held indefinitely at ambient temperature.
Routine handling calls for storage of the lyophilized powder at refrigerated temperatures, away from light, in a sealed container. Working solutions are often prepared in sterile water or buffer and kept cold between uses. Repeated freeze-thaw cycles are generally avoided because they can promote aggregation and loss of material. Laboratories usually record lot number, reconstitution date, and storage conditions so that any change in behavior can be traced to a specific preparation.
The molecule consists of 28 amino acid residues with an acetyl group attached to the N-terminal serine. Its sequence is acidic overall, with several glutamic and aspartic acid residues distributed along the chain and no cysteine, so disulfide bridges do not form. The peptide carries a net negative charge at physiological pH. Because the N-terminus is blocked, the intact molecule resists degradation by many aminopeptidases, which contributes to its stability in biological fluids.
The peptide is generated in cells by cleavage of prothymosin alpha, a larger acidic protein encoded by the PTMA gene. Prothymosin alpha is expressed in many tissues, not only in the thymus, and its functions include nuclear roles in chromatin-related processes. The 28-residue fragment corresponds to the N-terminal portion of that precursor. How the cleavage occurs and how the fragment's concentration is regulated remain open questions; circulating amounts are small and difficult to measure reliably with routine assays.
Thymosin alpha 1 is a short peptide first isolated from bovine thymus tissue in the early 1970s during fractionation work aimed at identifying factors that influence T cell development. It belongs to a family of acidic thymic peptides, and the original preparations contained several components that were later separated by chromatography. The compound is now produced synthetically rather than extracted from tissue, which removes batch variability tied to animal sourcing. Researchers describe it as an immunomodulatory peptide because laboratory studies show effects on several cell types of the innate and adaptive immune systems.
| Property | Value | Notes |
|---|---|---|
| Primary structure | 28 amino acid residues | N-terminally acetylated |
| Net charge at neutral pH | Negative | Acidic peptide |
| Typical purity assay | Reverse-phase HPLC | UV detection near 214 nm |
| Identity confirmation | Mass spectrometry | Matches expected molecular mass |
| Reconstitution solvent | Sterile water or saline | Follow supplier instructions |
Thymosin alpha-1 is a short peptide of 28 amino acid residues first described in the 1970s as a component of thymic extracts. Its N-terminal residue carries an acetyl group, and the sequence is highly conserved across mammalian species. The peptide is not encoded as a standalone gene product; it is released by proteolytic cleavage from the N-terminus of prothymosin alpha, a larger acidic nuclear protein. That precursor relationship places it within a broader family of thymic and immune-associated peptides that have been studied for decades.
The activity of this peptide is generally described as immunomodulatory rather than directly antimicrobial. Experimental work links it to signaling through certain Toll-like receptors on dendritic cells and to downstream maturation of antigen-presenting cells. Reported effects include expansion of T cell subsets, shifts in cytokine profiles, and increased natural killer cell activity. These observations come largely from cell culture and animal models, and the precise receptor-level events in humans remain incompletely characterized.
Lyophilized material is typically treated as a hygroscopic solid that should be brought to room temperature before the container is opened, which limits condensation on the powder. Reconstitution is commonly done with sterile water or a buffered diluent, and gentle mixing is preferred over vigorous agitation to reduce foaming and surface adsorption. Because peptides can bind to plastic and glass, diluents containing a small amount of carrier protein are sometimes used in laboratory work. Working solutions are generally aliquoted and prepared fresh rather than subjected to repeated freezing and thawing.
Stability depends on temperature, pH, and the number of freeze-thaw events the sample has experienced. Freeze-dried material is commonly held at -20 °C or colder, while reconstituted liquid is kept cold and used within a short window. Extreme pH and prolonged light exposure can promote deamidation, oxidation, or aggregation, particularly at asparagine and methionine positions. Adsorption to container walls can lower the measured concentration of a dilute solution even when the peptide molecules themselves remain intact.
Identity and purity are usually assessed by reversed-phase high-performance liquid chromatography, which separates the target peptide from truncated or chemically modified byproducts. Mass spectrometry confirms the expected molecular mass and can indicate acetylation state or sequence errors. Amino acid analysis and peptide mapping supply complementary sequence-level information, while endotoxin testing is relevant for preparations intended for cell or animal work. Purity figures reported by suppliers refer to the method used and are not directly comparable across laboratories unless conditions are stated.
Thymosin alpha 1 is a 28-amino-acid peptide first isolated from thymosin fraction 5, a bovine thymic extract. Its sequence begins with an acetylated serine residue and carries a high proportion of acidic residues, so the molecule has a net negative charge near neutral pH. Despite the shared name, it is unrelated in sequence to the thymosin beta family. Synthetic material prepared by solid-phase peptide synthesis is identical in sequence to the natural peptide.
Several names appear in the literature for this peptide, including thymalfasin and the abbreviation T-alpha-1. Naming conventions differ among research articles, regulatory documents, and supplier catalogs, which complicates literature searches. Both synthetic and recombinant production routes yield a peptide with the same 28-residue sequence as the thymic isolate. Because the thymosin label also covers unrelated peptides, sources should be compared by sequence rather than by name alone.
Thymosin alpha 1 was identified in 1977 as a component of thymosin fraction 5, a heterogeneous preparation used in early studies of thymic function. Investigators purified the active material and determined its amino acid sequence, which enabled chemical synthesis. Work in the following decades concentrated on T-cell maturation and immune reconstitution in animals and small human cohorts. Early preparations varied in composition, so results from that period are difficult to compare with studies using defined synthetic peptide.
Clinical research has examined the peptide in chronic hepatitis B and C, as a vaccine adjuvant, and in sepsis and oncology settings. Findings across trials are mixed; some report changes in selected immune markers, while others find no clear clinical benefit. Many studies are small and define outcomes differently, which limits comparison. Regulatory approval is confined to a few countries, and the compound is not an approved drug in the United States or most of Europe.
Long before the born secret issues associated with the restricted data provisions of the US Atomic Energy Act of 1946, the US Invention Secrecy Act of 1951, and the US Patent and Trademark Law Amendments Act of 1980 and/or the increasing concerns with respect to the on-going biopiracy of natural products, and in the early 20th-century atmosphere of cultural change — not only in the proliferation of vocational universities, rather than research universities, but also in the gradual move from the disciplinary concentration on "pure science" and, perhaps, aspects of "applied science", to that of fostering "industrial science" in both primary and secondary industries — the ethical question of whether or not those universities devoted to "pure science" (viz., the discovery/creation, distillation, refinement, diffusion, and the free dissemination of knowledge for the benefit of the public) should have any interest in "applied science", and further, whether they should have any commercial interest in the products of their research and, in particular, whether they should seek patents for their discoveries. In his 1926 Presidential address to the Society of American Bacteriologists (HZ.1), Hans Zinsser spoke against "the growing tendency on the part of medical scientific workers, and bacteriologists especially, to patent discoveries of practical therapeutic and public health value" (p.157).
Among measures it introduces is a licensing scheme for land where grouse shooting takes place, and regulations for traps. 22 March – A report prepared by Stirling University calls for artificial 3G football pitches to be banned in Scotland because they contain potentially cancer causing chemicals. Jasmin Paris from Midlothian becomes the first woman to complete the Barkley Marathons in the US state of Tennessee, doing so with one minute 39 seconds to spare of the 60-hour cut off. 27 March – Following a three-week hearing at Edinburgh Sheriff Court, former private school teacher John Brownlee, who worked at the Edinburgh Academy between 1967 and 1987, is found to have physically abused bos in his charge. He will not face trial though as he was earlier deemed to be medically unfit to do so. A group calling itself INC Ransom threatens to publish data stolen from NHS Dumfries and Galloway. VisitScotland announces that its 25 information centres will close over the next two years. 28 March – The Assisted Dying for Terminally Ill Adults (Scotland) Bill, a bill to legalise assisted dying in Scotland and drafted by Liberal Democrat MSP Liam McArthur, is introduced into the Scottish Parliament.
== Contraindications == Ioxaglic acid is contraindicated in people with hyperthyreosis because of the drug's iodine content. It must not be used for myelography (spinal cord imaging), for hysterosalpingography in women who are pregnant or have an acute inflammation in the pelvic region, or for arthrography if the joint is infected.
Bremelanotide, sold under the brand name Vyleesi, is a medication used to treat low sexual desire in women. Specifically, it is used for low sexual desire which occurs before menopause and is not due to medical problems, psychiatric problems, or problems within the relationship. It is given by an injection just under the skin of the thigh or abdomen. Common side effects include nausea, pain at the site of injection, and headache. It may also cause a temporary increase in blood pressure and decrease in heart rate after each dose, and darkening of the gums, face, and breasts. The medication is a peptide and acts by activating the melanocortin receptors. Bremelanotide was approved for medical use in the United States in 2019. It was developed by Palatin Technologies.
Sources: en.wikipedia.org
In May 2014, researchers announced that they had successfully introduced two new artificial nucleotides into bacterial DNA, alongside the four naturally occurring nucleotides, and by including individual artificial nucleotides in the culture media, were able to passage the bacteria 24 times; they did not create mRNA or proteins able to use the artificial nucleotides.
In Indonesia the third-generation Familia was marketed by Indomobil Group twice, the first time as the 323 hatchback from 1977 to 1980, and the second time around as the low-cost alternative of the popular Toyota Kijang and fellow Indomobil Group product's Suzuki Carry Extra/Futura; low-price "Mazda MR90" (hatchback) between December 1990 to 1993, "Mazda Baby Boomers" (hatchback) between 1993 and 1995, and as the "Mazda Vantrend" (station wagon and special limited order as high roof van or pickup) between 1993 and 1997. The Vantrend and its derivatives were also marketed as the Mazda M1400. The name MR90 stands for "Mobil Rakyat 90" (people's car for the 1990s) as it was intended to become a national car project. This was scuppered by the appearance of the Timor 515 project. The MR90 and its successors did see limited exports to small markets such as Fiji and Sri Lanka. There was also a better equipped GLX version available. The Baby Boomers was a lightly facelifted variant with new bumpers and a rear spoiler, for a more sporty appearance overall. The 1990s versions built by Indomobil have modernized headlights (same as on the Mazda 626 (GC), while Vantrend adopted the pre-facelift North American market quad headlights version) and bumpers. These alterations mean that the overall length increased, up to 3,970 mm (156 in) for the MR90 hatchback. Only the 70 PS (51 kW) UC 1.4-litre engine was offered, in combination with a five-speed transmission.
Middle ear and inner ear (barotitis or aerotitis) Paranasal sinuses (causing aerosinusitis) Lungs may be affected by both under-pressure or, more commonly, overpressure relative to the external pressure Eyes (the under-pressure air space is inside the diving mask or swimming goggles) Skin (when wearing a diving suit which creates an air space) Brain and cranium (temporal lobe injury secondary to temporal bone rupture) Teeth (causing barodontalgia, i.e., barometric pressure related dental pain, or dental fractures) Genital squeeze and associated urinary complications of P-valve use Intestinal barotrauma is caused by over-expansion of gas trapped in the intestines during ascent.
Sources: en.wikipedia.org
Radionuclides are present in many homes as they are used inside the most common household smoke detectors. The radionuclide used is americium-241, which is created by bombarding plutonium with neutrons in a nuclear reactor. It decays by emitting alpha particles and gamma radiation to become neptunium-237. Smoke detectors use a very small quantity of 241Am (about 0.29 micrograms per smoke detector) in the form of americium dioxide. 241Am is used as it emits alpha particles which ionize the air in the detector's ionization chamber. A small electric voltage is applied to the ionized air which gives rise to a small electric current. In the presence of smoke, some of the ions are neutralized, thereby decreasing the current, which activates the detector's alarm.
Whilst his heavy alcohol consumption is seen as a contributory factor to his final illness, Andrew Sinclair and George Tremlett express the view that Thomas was not an alcoholic. Likewise Constantine Fitzgibbon, his first biographer and friend, who was personally familiar with Thomas's drinking habits, notes that though there were multiple episodes of excessive alcohol consumption, there were also lengthy periods of relative abstinence.
John Russell (1893–1917), recipient of the Victoria Cross, born in Holyhead Ceinwen Rowlands (1905–1983), a Welsh concert soprano and recording artist, born in Holyhead R. S. Thomas (1913–2000), a Welsh poet and Anglican priest poet, grew up in Holyhead Cledwyn Hughes, Baron Cledwyn of Penrhos (1916–2001) MP & politician, born in Holyhead, attended Ysgol Uwchradd Caergybi Barbara Margaret Trimble (1921–1995) a British writer of over 20 crime, thriller and romance novels, born in Holyhead David Crystal (born 1941) linguist and chair of the charity behind Holyhead's Ucheldre Centre, lives in Holyhead Glenys Kinnock (1944-2023) a politician, MEP, educated at Holyhead High School Dawn French (born 1957 in Holyhead) comedian and actress, co-star in French and Saunders Albert Owen (born 1959 in Holyhead) politician, MP for Ynys Môn from 2001 to 2019. Kevin Johnson (born 1960 in Holyhead), a managing partner at Medicxi Ventures, a venture capital firm Jason Evans (born 1968 in Holyhead), a Welsh photographer and lecturer on photography Ben Crystal (born 1977), an English actor, author, and producer brought up in Holyhead Gareth Williams (1978–2010) worked for GCHQ and SIS died in suspicious circumstances
Sources: en.wikipedia.org
The lyophilized solid is normally held at 2 to 8 °C in a sealed, light-protected container. Dry storage limits both hydrolysis and microbial growth. Material kept this way remains stable for the shelf life stated by the supplier.
Reverse-phase HPLC separates the peptide from related impurities and yields a purity estimate. Mass spectrometry confirms the expected molecular mass and flags sequence errors. The two techniques are commonly reported together on a certificate of analysis.
Short exposure during handling is not considered a major problem for the dry powder. Prolonged storage at ambient temperature, especially of reconstituted solutions, raises the risk of degradation. Cold storage remains the standard practice for longer periods.
Thymosin fraction 5 is a mixture of many peptides obtained from thymus tissue, while thymosin alpha 1 is a single defined 28-residue molecule. The two names appear together in older literature because the purified peptide was first obtained from that mixture.